MRE Plus FIB-4 Beats FAST in Liver Fibrosis Detection

A combination of MRE and FIB-4 outperformed FAST in determining the presence of significant fibrosis among patients with NAFLD, according to a prospective cohort analysis.

Related Keywords

California ,United States ,San Diego ,Japan ,Yokohama ,Kanagawa ,Nobuharu Tamaki ,Zobair Younossi ,University Of California ,Pfizer ,Astrazeneca ,Siemens ,Research Center ,Yokohama Japan City University ,City University ,Nonalcoholic Fatty Liver Disease ,Vafld ,Biliary Disease ,Allbladder Disease ,Metabolic Syndrome ,Liver Fibrosis ,Cirrhosis ,Clinical Research ,Clinical Trials ,Linical Studies ,Nonalcoholic Steatohepatitis ,Ash Nonalcoholic Steatohepatitis ,Diagnostic Liver Biopsy ,Iopsy Of The Liver Diagnostic ,Liver Biopsy ,Biopsy ,